Oklahoma Study of Native American Pain Risk III: Stress and Resilience
Launched by UNIVERSITY OF OKLAHOMA · Feb 1, 2023
Trial Information
Current as of August 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Oklahoma Study of Native American Pain Risk III is a research project aimed at understanding how certain social factors, specifically discrimination and structural racism, affect chronic pain in Native American adults. Researchers want to find out how these negative experiences influence the way pain develops and what factors might help protect against these effects. They’re especially interested in the relationship between stress and resilience—essentially, how some people cope better than others in tough situations.
To participate in this study, you need to identify as Native American or American Indian and be between the ages of 65 and 74. However, if you have certain medical conditions, like ongoing pain or serious mental health issues, or if you are using specific medications that could affect the study, you may not be eligible. If you join, you can expect to share your experiences and possibly complete some assessments to help the researchers understand the links between discrimination, stress, and pain. This study is currently looking for participants, and your involvement could help improve understanding and treatment of pain in Native American communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identify as Native American/American Indian
- Exclusion Criteria:
- • \<18 years of age
- • Self-reported history of cardiovascular, neuroendocrine, musculoskeletal, or neurological disorders
- • Surrent chronic pain, defined as persistent, bothersome pain on more days than not for at least 3 months)
- • Self-reported current substance dependence
- • Sse of medication that could interfere with testing (e.g., recent use of analgesics, antidepressants, or anti-anxiety medications)
- • Inability to speak English
- • Current psychosis (assessed by Psychosis Screening Questionnaire)
- • Serious cognitive impairment (assessed by \<20 score on the Montreal Cognitive Assessment \[MoCA\])
- • Possible peripheral neuropathy (assessed by nerve conduction study)
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tulsa, Oklahoma, United States
Tulsa, Oklahoma, United States
Patients applied
Trial Officials
Jamie L Rhudy, PhD
Principal Investigator
University of Oklahoma
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials